Arnab Guha: New Insights into miRNA Therapies for Endometriosis and Depression
Arnab Guha, Founder, Director and Chief Visionary Officer at Impeccable Innovations Pvt. Ltd., shared a post on LinkedIn:
“Endometriosis induces depression in mouse models via miRNA dysregulation, leading to hippocampal shrinkage and reduced neurogenesis.
Targeting specific miRNAs – such as inhibitors for miR-125b and miR-451a, or a let-7b mimic – lowers depressive behaviors in tail suspension tests and restores hippocampal area, alongside upregulated genes like GAD45B, JUNB, ARC, and PROX1.
The findings build on prior research linking miRNAs like let-7b to endometriosis treatment in mice, suggesting potential miRNA-based therapies for alleviating psychological symptoms in affected patients.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jul 12, 2026, 17:02Are You Passionate About Patient Safety and Communication in Healthcare? – RCOG
-
Jul 12, 2026, 17:00Christopher Robinson: Ultrasound-Guided HIFU in Early-Onset Twin-Twin Transfusion Syndrome
-
Jul 12, 2026, 16:59Addressing Sexual Violence, A FIGO Committee on Women Facing Crises Consensus Statement – IJGO
-
Jul 12, 2026, 16:57Clinician vs. Embryologist, Same Cycle, Different Windows into Biology – Indore Infertility Clinic and IVF Center
-
Jul 12, 2026, 16:56Marco Zaccaria: Understanding Uterine Fibroids Through Nutrition and Lifestyle!
-
Jul 12, 2026, 16:54Camille Clare: ACOG Begins New Leadership Chapter with Inaugural Board Meeting!
-
Jul 12, 2026, 16:53Sandro Esteves: Scientific Exchange and Innovation in Male Fertility at London’s IVF Masterclass
-
Jul 12, 2026, 16:51George Woodhead: Sharing Our Work on Cryotransport of Vitrified Donor Oocytes at ESHRE!
-
Jul 12, 2026, 16:49How ESHRE 2026 Is Shaping the Future of Reproductive Medicine? – Umana Fertility